Tittawella I P
Mol Gen Genet. 1976 May 7;145(2):223-6. doi: 10.1007/BF00269598.
By using rifampicin to increase the rate of beta and beta' synthesis in a heterodiploid strain of E. coli carrying the mutation rifpr (Km7), which codes for a rifampicin sensitive RNA polymerase to which the drug binds weakly, and the dominant mutation rifRD, which codes for a rifampicin resistant RNA polymerase, the concentration of these subunits in the cell was increased 1.6 fold. Measurements made after removal of rifampicin from the cells showed that the excess beta and beta' subunits did not reduce the rate of their own synthesis below normal.
通过使用利福平来提高携带突变rifpr(Km7)的大肠杆菌异源二倍体菌株中β和β'亚基的合成速率,该突变编码一种对利福平敏感的RNA聚合酶,药物与之结合较弱,以及显性突变rifRD,其编码一种对利福平耐药的RNA聚合酶,细胞中这些亚基的浓度增加了1.6倍。从细胞中去除利福平后进行的测量表明,过量的β和β'亚基并没有将它们自身的合成速率降低到正常水平以下。